IgE immune responses to a variety of environmental and synthetic agents are the hallmark of certain allergic diseases that affect 5-15% of the population. Provided herein is a antibody against trinitrophenyl (TNP).
Figure 1 Groups of three to five F1 mice were immunized with SRBC-TNP and HRBC preincubated with 0–50 μg of IgE anti-TNP (IGELb4) (solid circles) or IgG2b anti-TNP (1B4) (open circles). Five days later the direct SRBC-specific (solid line) and HRBC-specific (broken line) PFC/spleen were assayed.
Karlsson, M. C., Wernersson, S., de Ståhl, T. D., Gustavsson, S., & Heyman, B. (1999). Efficient IgG-mediated suppression of primary antibody responses in Fcγ receptor-deficient mice. Proceedings of the National Academy of Sciences, 96(5), 2244-2249.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-G064R | Anti-TNP immunotoxin (IgM)-RTA | Cytotoxicity assay, Function study |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# FAMAB-0288YC, RRID: AB_3111325)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.